After standard fasting times, all children had topical anaesthetic EMLA ® (AstraZeneca Pty Ltd, Cairo, Egypt) applied to the dorsum of both hands one hour before surgery. Midazolam 0.5 mg/kg was given orally as a preoperative sedation 30 minutes prior to the anaesthesia. A peripheral intravenous line was inserted on arrival in the operating theatre and the assigned study drug was administered over a five minute period just before spinal puncture.
Spinal puncture was done in the lateral decubitus position with a midline approach at L4 to 5. We used 25 gauge 55 mm Quincke spinal needles. Correct placement of the spinal needle was verified by a free flow of cerebrospinal fluid. Hyperbaric bupivacaine 0.5% (0.5 mg/kg) was used to achieve subarachnoid block. Monitoring of children included pulse oximetry, non-invasive blood pressure, electrocardiography and core temperature by tympanic probe. The children were sedated with intravenous thiopentone 2 mg/kg. If any subject cried or moved the upper body and hands to interfere with the procedure, 1 µg/kg fentanyl was given as a supplemental analgesia and sedation.
Sensory block was assessed 10 minutes after injection of bupivacaine by bilateral pinprick test at each dermatome to elicit grimace or acknowledgement of pain. Motor block was assessed using the Bromage scale 9 recording the ability to flex hip, knee and ankle. Shivering was assessed using a modified scale from Tsai and Chu (0=no shivering, 1=mild fasciculations on face and neck, 2=visible tremor involving more than one muscle group, 3=gross muscle activity involving the whole body) 10 .
Core temperature by tympanic thermometer and shivering were recorded before spinal puncture and 15, 30, 60 and 90 minutes after spinal puncture. All intravenous fluids during surgery were warmed to 37°C and the temperature of the operating room was kept at 27°C. The sample size was calculated using the following assumptions: the incidence of shivering in the control group would be 15% in keeping with a previous study 11 . Power analysis identified 40 patients per group, required to detect 25% difference between groups with a power 80% and a significance level of 0.05.
Comparison of demographic data between groups was done by Student's t-test. Comparison between groups was done by Fisher's exact test (twotailed). Repeated data on the same participants (core temperature, heart rate, non-invasive blood pressure) were analysed by repeated measures (analysis of variance). P <0.05 was considered statistically significant.
RESULTS
Demographic data, duration of surgery and volume of infused fluid are presented in Table 1 . The two groups were comparable with respect to age, weight and volume of fluid given intraoperatively.
Nine subjects cried or moved the upper body and hands during the procedure and received 1 µg/kg fentanyl (five patients in the control group and four patients in the granisetron group). There was a 100% success rate in achieving sensory and motor block within 10 minutes after spinal injection.
With respect to the motor block, 35 children in group 1 and 33 children in group 2 showed motor block grade three; five children in group 1 and seven children in group 2 showed motor block grade two (P=0.75). With respect to sensory block, the range in all children in both groups was between T4 and T7. Ten children in group 1 and 12 children in group 2 showed a sensory block to T4, while the sensory block reached T7 in 11 children in group 1 and 10 children in group 2. The other children in both groups were in between these levels.
There was no significant difference in core temperature (Table 1) , heart rate, blood pressure and oxygen saturation between the groups at any time. Shivering did not occur in any patient in group 1; it occurred in six patients in group 2 ( Table 1 , P=0.025). All patients who showed shivering received intravenous pethidine 0.5 mg/kg to stop the shivering, which was effective in all cases.
DISCUSSION
These findings indicate that granisetron was effective in reducing shivering. There was no incidence of shivering in the granisetron group, while it occurred in six patients in the control group despite the absence of any significant difference in core temperature or block characteristics between both groups.
The exact mechanism of post-spinal shivering has not been fully elucidated. Hypotheses include internal redistribution of heat from the core to the peripheral compartment [12] [13] [14] , loss of thermoregulatory vasoconstriction below the level of the blockade (which leads to increase heat loss from body surfaces) or altered thermoregulation characterised by a small decrease in vasoconstriction and a slight increase in the sweating threshold. Interestingly, the major difference in thermal control between adults and children is that in children the surface area per kilogram is larger than adults, together with thinner skin and lower fat content that allows a higher heat loss 15 .
There are several risk factors for shivering during spinal anaesthesia such as age, level of sensory block, temperature of the operating room, wound exposure and amount and temperature of infusion fluids 16 . In this study, there were no significant differences between the groups in any of those factors.
Various drugs have been used to prevent postoperative shivering. The ideal drug has not yet been found, although 5-hydroxytryptamine may influence both heat production and heat loss pathways 17 . Powell and Buggy 6 reported that shivering was observed in 57, 33 and 15% of patients receiving placebo, ondansetron 4 mg, and ondansetron 8 mg respectively. Also, Bock and colleagues 18 reported that dolasetron 1 mg.kg -1 decreased the incidence of shivering from 62 to 27%. The incidence of shivering (27%) in patients who received dolasetron in their study was more than the incidence of shivering in the patients who received granisetron in the study of Iqbal and colleagues 19 (17%). So, we decided using granisetron in our study for its potentillay greater beneficial effect.
Other pharmacological agents have been used for the treatment and prevention of shivering including tramadol, midazolam, ketamine, pethidine and clonidine 1, 11, 19 .
Pethidine has been shown to be one of the most effective agents to prevent postoperative shivering 20, 21 . The anti-shivering action of pethidine is also not completely understood 20 . The major concern of pethidine is that it can cause respiratory depression, especially in the presence of previously administered anaesthetics and especially in children. A higher incidence of postoperative nausea and vomiting are also important side-effects of pethidine 21 .
Clonidine may be associated with hypotension and sedation 11, 19 . Also, tramadol is associated with more frequent incidence of side-effects such as nausea, vomiting and dizziness. Hallucinations are a wellknown side-effect of ketamine, which may limit its use 1 . In contrast, 5-HT3 antagonists appear to be relatively free of side-effects although this has not been confirmed in large studies.
A possible limitation of this study is the incidence of shivering in the control group. In another study an incidence of 3.5% was found, with a significantly lower incidence in children who received a caudal anaesthesia 22 . This is a much lower reported incidence than the one used by the authors and could potentially influence the power analysis.
CONCLUSION
Our findings suggest that granisetron is an effective agent to reduce shivering in children from two to five years of age after spinal anaesthesia.
